查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細菌性疾病診斷的全球市場（~2033）：按類型、產品、技術和最終用戶、區域前景和競爭策略分類的規模和預測
市場調查報告書
商品編碼
1351344

細菌性疾病診斷的全球市場（~2033）：按類型、產品、技術和最終用戶、區域前景和競爭策略分類的規模和預測

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 221 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

細菌性疾病診斷市場規模預計將以 6.5% 的年複合成長率成長。

細菌有多種類型。大多數對身體有益，有些具有傳染性，病原體是任何可以引起感染疾病的細菌。準確診斷細菌感染對於防止不必要地使用抗生素並提供適當的治療至關重要。確認細菌感染通常需要多種診斷方法，因為它涉及細菌的存在以及發炎和全身功能障礙。

此外，導致 COVID-19 的新型冠狀病毒引發了各國政府對加速實驗室檢測程序的支持。儘管疫情導致多個行業的收入減少，但 COVID-19 檢測的應用幫助了感染疾病診斷市場，並加快了法規機構對 COVID-19 診斷產品的批准。

本報告調查了全球細菌性疾病診斷市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、按類型、產品、區域等詳細分析以及競爭形勢。的主要企業。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 市場動態

  • 促進因素、抑制因素、機會與挑戰分析
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • COVID-19 對全球細菌性疾病診斷市場的影響

第5章 市場變數與預測

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭形勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章 全球細菌性疾病診斷市場：按類型

  • 市場規模佔有率/預測
  • 細菌性皮膚感染疾病
  • 食物中毒
  • 性行為感染傳染病

第8章 全球細菌性疾病診斷市場：按產品

  • 市場規模佔有率/預測
  • 消耗品
  • 裝置

第9章 全球細菌性疾病診斷市場：依技術分類

  • 市場規模佔有率/預測
  • DNA微陣列
  • 免疫診斷
  • 恒溫核酸增幅技術
  • 聚合酶鍊式反應

第10章 全球細菌性疾病診斷市場：依最終用戶分類

  • 市場規模佔有率/預測
  • 醫院
  • 實驗室
  • 研究中心

第11章全球細菌性疾病診斷市場預測

  • 市場規模/市場佔有率

第12章全球細菌性疾病診斷市場：按類型

  • 市場規模/市場佔有率

第13章全球細菌性疾病診斷市場：按產品

  • 市場規模/市場佔有率

第14章全球細菌性疾病診斷市場：依技術分類

  • 市場規模/市場佔有率

第15章全球細菌性疾病診斷市場：依最終用戶分類

  • 市場規模/市場佔有率

第16章全球細菌性疾病診斷市場：按地區

  • 市場規模/市場佔有率
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第17章公司簡介

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp
  • DiaSorin SpA
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • GENERI BIOTECH sro
  • Great Basin Scientific
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • T2 Biosystems Inc.
  • Takara Bio Inc.
  • 其他

第18章簡稱表

第19章參考鏈接

第20章結論

第21章調查範圍

簡介目錄
Product Code: HLCA2357

Introduction and Overview

According to SPER Market Research, 'Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Bacterial Disease Diagnostics Market is predicted to reach with a CAGR of 6.5%.

The several forms of bacteria. However, the majority of them are good for the body while some of them are contagious. Pathogens include all bacteria that are responsible for infectious diseases. To prevent the needless use of antibiotics and to target the right therapy, an accurate diagnosis of bacterial infection is essential. In order to confirm a bacterial infection, more than one diagnostic method is typically needed because it involves the presence of germs as well as inflammation or systemic dysfunction.

Furthermore, the new coronavirus that causes COVID-19 has sparked support from governments all over the world for laboratories to expedite testing procedures. Although the pandemic reduced revenues in several industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. The regulatory authorities hastened the licencing of COVID-19 diagnostic products.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Type, By Product, By Technology, By End User
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., Meridian Bioscience Inc., Perkin Elmer Inc., Quest Diagnostics Inc., and Takara Bio Inc., Others

Market Segmentation:

  • By Type: Based on the Type, Global Bacterial Disease Diagnostics Market is segmented as; Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections.
  • By Product: Based on the Product, Global Bacterial Disease Diagnostics Market is segmented as; Consumables, Instruments.
  • By End User: Based on the End User, Global Bacterial Disease Diagnostics Market is segmented as; Hospitals, Labs, Research Centres.
  • By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)

  • 7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Bacterial Skin Infections
  • 7.3. Foodborne Infections
  • 7.4. Sexually Transmitted Infections

8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)

  • 8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
  • 8.2. Consumables
  • 8.3. Instruments

9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)

  • 9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
  • 9.2. DNA Microarray
  • 9.3. Immunodiagnostics
  • 9.4. Isothermal Nucleic Acid Amplification Technology
  • 9.5. Polymerase Chain Reaction

10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)

  • 10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
  • 10.2. Hospitals
  • 10.3. Labs
  • 10.4. Research Centres

11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)

  • 12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
  • 12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)

  • 13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
  • 13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)

  • 14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
  • 14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)

  • 15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
  • 15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
  • 16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Abbott Laboratories
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Accelerate Diagnostics Inc.
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Becton Dickinson and Co.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Bio Rad Laboratories Inc.
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. bioMerieux SA
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Bruker Corp.
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Danaher Corp
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. DiaSorin SpA
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. EKF Diagnostics Holdings Plc
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. F. Hoffmann La Roche Ltd.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. GENERI BIOTECH s.r.o.
    • 17.11.1. Company details
    • 17.11.2. Financial outlook
    • 17.11.3. Product summary
    • 17.11.4. Recent developments
  • 17.12. Great Basin Scientific
    • 17.12.1. Company details
    • 17.12.2. Financial outlook
    • 17.12.3. Product summary
    • 17.12.4. Recent developments
  • 17.13. Hologic Inc.
    • 17.13.1. Company details
    • 17.13.2. Financial outlook
    • 17.13.3. Product summary
    • 17.13.4. Recent developments
  • 17.14. Meridian Bioscience Inc.
    • 17.14.1. Company details
    • 17.14.2. Financial outlook
    • 17.14.3. Product summary
    • 17.14.4. Recent developments
  • 17.15. Perkin Elmer Inc.
    • 17.15.1. Company details
    • 17.15.2. Financial outlook
    • 17.15.3. Product summary
    • 17.15.4. Recent developments
  • 17.16. QIAGEN NV
    • 17.16.1. Company details
    • 17.16.2. Financial outlook
    • 17.16.3. Product summary
    • 17.16.4. Recent developments
  • 17.17. Quest Diagnostics Inc.
    • 17.17.1. Company details
    • 17.17.2. Financial outlook
    • 17.17.3. Product summary
    • 17.17.4. Recent developments
  • 17.18. Siemens AG
    • 17.18.1. Company details
    • 17.18.2. Financial outlook
    • 17.18.3. Product summary
    • 17.18.4. Recent developments
  • 17.19. T2 Biosystems Inc.
    • 17.19.1. Company details
    • 17.19.2. Financial outlook
    • 17.19.3. Product summary
    • 17.19.4. Recent developments
  • 17.20. Takara Bio Inc.
    • 17.20.1. Company details
    • 17.20.2. Financial outlook
    • 17.20.3. Product summary
    • 17.20.4. Recent developments
  • 17.21. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope